Edu Butyrose
  • Responsabile scientifico
  • Articoli
    • BARRIERA EPITELIALE INTESTINALE
    • BUTIRRATO
    • COVID-19
    • GVHD – Graft-versus-Host Disease / Malattia del trapianto contro l’ospite
    • IBS
    • IBD
    • IDROSADENITE SUPPURATIVA
    • LINEE GUIDA
    • MALATTIE METABOLICHE
    • MALATTIA DIVERTICOLARE
    • RADIOTERAPIA
    • RIGENERAZIONE CUTANEA
  • Interviste
  • Eventi
  • Studi in corso
  • Riviste
  • Documenti utili
  • LSC
  • SILA
  • Logout
Seleziona una pagina
Therapeutic Effects of Butyrate on Pediatric Obesity A Randomized Clinical Trial

Therapeutic Effects of Butyrate on Pediatric Obesity A Randomized Clinical Trial

da admin | Mar 20, 2024 | MALATTIE METABOLICHE

Non hai il permesso di visualizzare questo contenuto.

Therapeutic Effects of Butyrate on Pediatric Obesity A Randomized Clinical Trial

da admin | Nov 14, 2023 | RACCOLTA BIBLIOGRAFICA

Therapeutic Effects of Butyrate on Pediatric ObesityA Randomized Clinical Trial Serena Coppola, Rita Nocerino, Lorella Paparo, Giorgio Bedogni, Antonio Calignano, Carmen Di Scala, Anna Fiorenza de Giovanni di Santa Severina, Francesca De Filippis, Danilo Ercolini,...

Articoli recenti

  • Global guidelines on diverticular disease of the colon: the Fiesole Consensus report
  • Gut microbiota in symptomatic uncomplicated diverticular disease stratifies by severity of abdominal pain
  • Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease
  • Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study
  • Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners

Commenti recenti

    ideA-Z Project in progress S.r.l. | P.IVA: IT03373190960
    Corso Giacomo Matteotti, 48 – 20081 – Abbiategrasso (MI) | info@idea-z.it